Literature DB >> 1637902

Oral contraceptive use and the risk of inflammatory bowel disease.

R S Sandler1, J I Wurzelmann, C M Lyles.   

Abstract

We used rosters of the Crohn's and Colitis Foundation of America to identify potential cases and peer-nominated controls to explore the reported association between oral contraceptives and inflammatory bowel disease. Overall, women who used oral contraceptives were at increased risk of developing Crohn's disease (odds ratio = 1.49, 95% confidence interval (CI) = 0.99-2.26). The findings persisted after adjustment for age at symptom onset, decade of onset, education, marital status, and location of disease. There was an interaction with cigarette smoking; the risk associated with oral contraceptives was elevated in current smokers (odds ratio = 2.64, 95% CI = 1.22-5.75), but not in former smokers or never-smokers. The risk was not elevated for ulcerative colitis (odds ratio = 1.10, 95% CI = 0.65-1.85).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637902     DOI: 10.1097/00001648-199207000-00014

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  7 in total

1.  Oral contraceptives, reproductive factors and risk of inflammatory bowel disease.

Authors:  Hamed Khalili; Leslie M Higuchi; Ashwin N Ananthakrishnan; James M Richter; Diane Feskanich; Charles S Fuchs; Andrew T Chan
Journal:  Gut       Date:  2012-05-22       Impact factor: 23.059

Review 2.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

3.  Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease.

Authors:  P G Godet; G R May; L R Sutherland
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

Review 4.  Influence of environmental factors in the development of inflammatory bowel diseases.

Authors:  Evangelia Legaki; Maria Gazouli
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

5.  Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study.

Authors:  J Cosnes; F Carbonnel; F Carrat; L Beaugerie; J P Gendre
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

6.  Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA.

Authors:  Peiqi Wang; Jun Hu; Shadi Ghadermarzi; Ali Raza; Douglas O'Connell; Amy Xiao; Faraz Ayyaz; Min Zhi; Yuanqi Zhang; Nimisha K Parekh; Mark Lazarev; Alyssa Parian; Steven R Brant; Marshall Bedine; Brindusa Truta; Pinjin Hu; Rupa Banerjee; Susan M Hutfless
Journal:  Dig Dis Sci       Date:  2018-06-04       Impact factor: 3.199

7.  The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases.

Authors:  Santosh Sanagapalli; Yanna Ko; Viraj Kariyawasam; Siew C Ng; Whitney Tang; Hithanadura Janaka de Silva; Minhu Chen; Kaichun Wu; Satimai Aniwan; Ka Kei Ng; David Ong; Qin Ouyang; Ida Hilmi; Marcellus Simadibrata; Pises Pisespongsa; Saranya Gopikrishna; Rupert W Leong
Journal:  Intest Res       Date:  2018-07-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.